Ligand validation:4RT0

C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)

C2E is a Ligand Of Interest in 4RT0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RT0_C2E_A_202	98%	13%	0.05	0.974	2.34	1.6	11	13	0	0	100%	1
4RT0_C2E_C_202	95%	14%	0.06	0.965	2.39	1.49	12	9	0	0	100%	1
4RT0_C2E_B_202	95%	13%	0.061	0.962	2.47	1.52	17	9	1	0	100%	1
4RT0_C2E_C_201	74%	11%	0.085	0.913	2.55	1.68	14	12	0	0	100%	1
4RT0_C2E_B_201	71%	13%	0.086	0.905	2.52	1.5	14	9	0	0	100%	1
4RT0_C2E_A_201	71%	11%	0.093	0.912	2.53	1.68	16	12	2	0	100%	1
4RT1_C2E_B_201	99%	17%	0.054	0.982	2.38	1.24	11	7	0	0	100%	1
4XRN_C2E_C_203	80%	2%	0.112	0.961	5.12	1.68	35	12	2	0	100%	1
8U0I_C2E_A_102	100%	40%	0.042	0.984	1.15	1.19	6	6	0	0	100%	1
4URG_C2E_A_1241	97%	16%	0.065	0.983	2.24	1.49	10	10	0	0	100%	1
5HTL_C2E_B_201	97%	17%	0.057	0.973	2.34	1.3	15	8	1	0	100%	1
2RDE_C2E_B_301	97%	45%	0.067	0.983	0.93	1.18	2	6	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.